KIDTRAYZE perfusive solution concentrate medication leaflet

B05XA31 combinations • Blood and blood forming organs | I.v. solution additives | Electrolyte solutions

General data about KIDTRAYZE

Substance: combinations

Date of last drug list: 01-09-2023

Commercial code: W69712001

Pharmaceutical form: perfusive solution concentrate

Quantity: 20

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: FRESENIUS KABI NORGE AS - NORVEGIA

Holder: FRESENIUS KABI ROMANIA S.R.L. - ROMANIA

Number: 15079/2023/01

Shelf life: 3 years-after packing for marketing;after the first opening-it is used immediately